利用网络目标理论有效预测药物疾病相互作用:一种转移学习方法
Qingyuan Liu1,2, Zizhen Chen1, Boyang Wang2
1Department of Molecular Pharmacology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China.
这项研究引入了一种新的深度学习模型,用于预测药物-疾病相互作用,识别癌症治疗的新型协同药物组合. 该模型通过先进的网络分析来增强药物发现和治疗开发.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物发现依赖于有效的方法来识别潜在的治疗方法.
- 预测药物与疾病的相互作用对于开发创新的治疗方法至关重要.
- 现有的模型在处理大型数据集和平衡样本类型方面面临着挑战.
研究的目的:
- 开发一种用于预测药物与疾病相互作用的新型转移学习模型.
- 利用网络目标理论和深度学习来增强药物特征提取.
- 确定针对特定疾病,包括癌症的新奇协同药物组合.
主要方法:
- 使用转移学习模型,将深度学习与生物分子网络集成在一起.
- 采用网络技术从现有知识中提取精确的药物特征.
- 解决了在数据集中平衡大规模正负样本的挑战.
主要成果:
- 确定了88161种药物疾病相互作用,涉及7940种药物和2986种疾病.
- 实现了0.9298的曲线下面积 (AUC) 和0.6316的F1得分,用于相互作用预测.
- 成功预测了F1分数为0.7746的药物组合,并确定了两种癌症的新奇协同组合.
结论:
- 这种新型模型显著改善了药物与疾病相互作用和药物组合的预测.
- 鉴定出的协同作用药物组合显示出有效的癌症治疗方案的潜力.
- 这种方法为加速药物开发和个性化医疗提供了一个强大的工具.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
07:35A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
相关概念视频
Drug Discovery: Overview
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Analysis of Population Pharmacokinetic Data
Physiological Pharmacokinetic Models: Assumption with Protein Binding
